These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2380943)

  • 21. A systematic review of patient information leaflets for hypertension.
    Fitzmaurice DA; Adams JL
    J Hum Hypertens; 2000 Apr; 14(4):259-62. PubMed ID: 10805051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey.
    Harris K; Dickinson R; Raynor DK; MacDonald J; Knapp P
    Drug Saf; 2015 Aug; 38(8):721-7. PubMed ID: 26100144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative attitudes to verbal and written medication information among hospital outpatients.
    Harvey JL; Plumridge RJ
    DICP; 1991 Sep; 25(9):925-8. PubMed ID: 1949967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient information booklets for Asian patients with ulcerative colitis.
    Conroy SP; Mayberry JF
    Public Health; 2001 Nov; 115(6):418-20. PubMed ID: 11781853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. It's for your benefit: exploring patients' opinions about the inclusion of textual and numerical benefit information in medicine leaflets.
    Hamrosi K; Dickinson R; Knapp P; Raynor DK; Krass I; Sowter J; Aslani P
    Int J Pharm Pract; 2013 Aug; 21(4):216-25. PubMed ID: 23419118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public.
    Mottram DR; Reed C
    J Clin Pharm Ther; 1997 Apr; 22(2):127-34. PubMed ID: 9373811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' use and perception of medication information leaflets.
    Nathan JP; Zerilli T; Cicero LA; Rosenberg JM
    Ann Pharmacother; 2007 May; 41(5):777-82. PubMed ID: 17405820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
    Raynor DK; Svarstad B; Knapp P; Aslani P; Rogers MB; Koo M; Krass I; Silcock J
    J Am Pharm Assoc (2003); 2007; 47(6):717-24. PubMed ID: 18032134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    Expert Opin Drug Saf; 2016; 15(4):417-26. PubMed ID: 26742855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines.
    Raynor DK; Blenkinsopp A; Knapp P; Grime J; Nicolson DJ; Pollock K; Dorer G; Gilbody S; Dickinson D; Maule AJ; Spoor P
    Health Technol Assess; 2007 Feb; 11(5):iii, 1-160. PubMed ID: 17280623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of drug information leaflets for non-steroidal anti-inflammatory drugs in Palestine: local versus imported products.
    Arandy DA; Abu-Hashia MW; Al-Hroub BM; Qatmosh SA; Koni AA; Qeeno BG; Al-Jabi SW; Zyoud SH
    BMC Health Serv Res; 2019 Nov; 19(1):892. PubMed ID: 31771571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the usability of patient information leaflets.
    Pander Maat H; Lentz L
    Patient Educ Couns; 2010 Jul; 80(1):113-9. PubMed ID: 19854022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of written prescription information provided in community pharmacies: a study in eight states.
    Svarstad BL; Bultman DC; Mount JK; Tabak ER
    J Am Pharm Assoc (2003); 2003; 43(3):383-93. PubMed ID: 12836789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How does the side-effect information in patient information leaflets influence peoples' side-effect expectations? A cross-sectional national survey of 18- to 65-year-olds in England.
    Webster RK; Weinman J; Rubin GJ
    Health Expect; 2017 Dec; 20(6):1411-1420. PubMed ID: 28618140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating genetics leaflets into languages other than English: lessons from an assessment of Urdu materials.
    Shaw A; Ahmed M
    J Genet Couns; 2004 Aug; 13(4):321-42. PubMed ID: 19736697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medicine information leaflets fail concordance test.
    Raynor DK; Britten N
    BMJ; 2001 Jun; 322(7301):1541. PubMed ID: 11439986
    [No Abstract]   [Full Text] [Related]  

  • 37. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.
    Kirby N; Shepherd V; Howick J; Betteridge S; Hood K
    Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring consumer opinions on the presentation of side-effects information in Australian Consumer Medicine Information leaflets.
    Tong V; Raynor DK; Blalock SJ; Aslani P
    Health Expect; 2016 Jun; 19(3):543-56. PubMed ID: 24905668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of the Patient Information Leaflet in Patients'Medication Therapy: A Case Study within the Kumasi Metropolis of Ghana.
    Owusu FWA; Yeboah GN; Aboagye RA; Amengor CDK; Entsie P
    ScientificWorldJournal; 2020; 2020():2489137. PubMed ID: 33149725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction.
    Oldman M; Moore D; Collins S
    Br J Anaesth; 2004 Jun; 92(6):854-8. PubMed ID: 15064254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.